111 related articles for article (PubMed ID: 2696631)
1. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
Rao MS; Reddy JK
Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
[No Abstract] [Full Text] [Related]
2. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
[TBL] [Abstract][Full Text] [Related]
3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.
Conway JG; Cattley RC; Popp JA; Butterworth BE
Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637
[No Abstract] [Full Text] [Related]
5. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.
Reddy JK; Rao MS; Azarnoff DL; Sell S
Cancer Res; 1979 Jan; 39(1):152-61. PubMed ID: 83907
[No Abstract] [Full Text] [Related]
7. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
Popp JA; Cattley RC; Miller RT; Marsman DS
Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
[No Abstract] [Full Text] [Related]
8. Peroxisome proliferation and hepatocarcinogenesis.
Reddy JK; Rao MS
IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
[No Abstract] [Full Text] [Related]
9. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
10. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
Cattley RC; Miller RT; Corton JC
Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
[TBL] [Abstract][Full Text] [Related]
12. Hepatocarcinogenesis of peroxisome proliferators.
Rao MS; Reddy JK
Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
[No Abstract] [Full Text] [Related]
13. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
[TBL] [Abstract][Full Text] [Related]
14. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of rodent liver carcinogenesis.
Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
[TBL] [Abstract][Full Text] [Related]
16. Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat.
Farber E
Monogr Pathol; 1987; (28):199-222. PubMed ID: 3023976
[No Abstract] [Full Text] [Related]
17. Hepatocarcinogenicity of dehydroepiandrosterone in the rat.
Rao MS; Subbarao V; Yeldandi AV; Reddy JK
Cancer Res; 1992 May; 52(10):2977-9. PubMed ID: 1316232
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
19. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate.
Nagai MK; Farber E
Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397
[TBL] [Abstract][Full Text] [Related]
20. Cell biology of hepatocarcinogenesis.
Saeter G; Seglen PO
Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
